Physician profile
Christopher Chen
NPI 1851603674
$369,651.45
in general payments reported to CMS, 2019-2025
99 companies · $60K in 2025
The $60K reported for 2025 was more than what 97% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $31K · 2021: $30K · 2022: $68K · 2023: $57K · 2024: $92K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $86K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Travel and Lodging: $32K · Consulting Fee: $18K · Food and Beverage: $17K · Education: $614 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $85,546.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,376.00 |
| Travel and Lodging | $32,235.14 |
| Consulting Fee | $18,376.25 |
| Food and Beverage | $17,371.86 |
| Education | $613.94 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $154,095.84 | 2019-2025 | Jakafi, Jakafi, Monjuvi |
| Pharmacosmos Therapeutics INC. | $140,992.98 | 2020-2025 | Monoferric |
| Bayer Healthcare Pharmaceuticals INC. | $20,526.33 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $9,972.17 | 2019-2025 | Imfinzi, Truqap, Enhertu |
| Sobi, INC | $5,184.16 | 2022-2025 | |
| Exelixis INC. | $4,103.91 | 2019-2025 | Cabometyx |
| Regeneron Pharmaceuticals, INC. | $3,849.92 | 2023-2024 | Libtayo |
| Pharmaessentia USA Corporation | $3,356.67 | 2022-2025 | Besremi |
| Abbvie INC. | $2,861.89 | 2019-2025 | |
| Stemline Therapeutics INC. | $2,737.51 | 2019-2025 | Orserdu, Elzonris |
| Novartis Pharmaceuticals Corporation | $1,922.11 | 2019-2025 | Kisqali |
| Janssen Biotech, INC. | $1,732.22 | 2019-2025 | Darzalex, Tecvayli, Carvykti |
| E.R. Squibb & Sons, L.L.C. | $1,586.53 | 2019-2025 | Opdivo, Abecma, Opdualag |
| Daiichi Sankyo INC. | $1,335.22 | 2021-2025 | Enhertu, Injectafer, Vanflyta |
| Merck Sharp & Dohme LLC | $1,316.96 | 2019-2025 | Keytruda, Welireg, Lynparza |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $1,049.10 | 2019-2023 | Tukysa, Padcev, Adcetris |
| Pfizer INC. | $905.05 | 2019-2025 | |
| Amgen INC. | $730.30 | 2019-2023 | Lumakras, Kyprolis, Blincyto |
| Celgene Corporation | $717.73 | 2019-2025 | Reblozyl, Pomalyst |
| Genzyme Corporation | $530.82 | 2019-2025 | |
| Beigene, Ltd. | $525.00 | 2021 | |
| Gilead Sciences, INC. | $497.34 | 2019-2025 | Trodelvy |
| Astellas Pharma US INC | $464.99 | 2019-2024 | Padcev, Xtandi, Xospata |
| Rigel Pharmaceuticals, INC. | $462.77 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Takeda Pharmaceuticals U.S.A., INC. | $439.45 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Glaxosmithkline, LLC. | $406.50 | 2021-2025 | Zejula, Jemperli, Ojjaara |
| Eisai INC. | $378.97 | 2019-2025 | |
| Genentech USA, INC. | $339.96 | 2019-2025 | Phesgo, Polivy, Columvi |
| Lilly USA, LLC | $331.34 | 2019-2025 | Jaypirca, Verzenio |
| Dova Pharmaceuticals | $311.41 | 2019-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $273.95 | 2019-2022 | |
| Mirati Therapeutics, INC. | $249.96 | 2023-2024 | Krazati |
| Alexion Pharmaceuticals, INC. | $239.23 | 2020-2025 | Ultomiris |
| Regeneron Healthcare Solutions, INC. | $215.50 | 2019-2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.01 | 2019-2024 | Gilotrif |
| Myriad Genetic Laboratories, INC. | $214.89 | 2020-2025 | Myrisk |
| Kite Pharma, INC. | $204.78 | 2021-2025 | Yescarta |
| Karyopharm Therapeutics INC. | $203.42 | 2020-2024 | Xpovio |
| Genmab U.S., INC. | $199.41 | 2024-2025 | Tivdak, Epkinly |
| Ipsen Biopharmaceuticals, INC | $195.00 | 2019-2025 | Onivyde |
| Jazz Pharmaceuticals INC. | $187.71 | 2020-2024 | |
| Adaptive Biotechnologies Corporation | $164.85 | 2022-2025 | Clonoseq |
| Beigene USA, INC. | $153.41 | 2020-2024 | Brukinsa |
| Emd Serono, INC. | $147.03 | 2019-2025 | |
| Galderma Laboratories, L.P. | $146.99 | 2024 | |
| Myovant Sciences INC. | $134.91 | 2022 | |
| Aadi Bioscience, INC. | $124.60 | 2024 | Fyarro |
| Taiho Oncology, INC. | $124.14 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $122.14 | 2019-2024 | |
| Foundation Medicine, INC. | $116.94 | 2019 | |
| Tersera Therapeutics LLC | $115.98 | 2021-2025 | Zoladex |
| Array Biopharma INC | $112.96 | 2024-2025 | Mektovi, Braftovi, Tukysa |
| Blueprint Medicines Corporation | $111.96 | 2021-2024 | Ayvakit |
| Clovis Oncology, INC. | $108.30 | 2019-2022 | |
| Kyowa Kirin, INC. | $105.09 | 2020-2025 | Poteligeo |
| Eusa Pharma (US) LLC | $98.18 | 2019-2021 | |
| Servier Pharmaceuticals LLC | $95.46 | 2021-2024 | |
| Intuitive Surgical, INC. | $89.69 | 2023 | Da Vinci Surgical System |
| Aveo Pharmaceuticals, INC. | $88.35 | 2021-2024 | |
| Shield Therapeutics INC | $84.72 | 2024 | |
| Sumitomo Pharma America, INC. | $81.46 | 2023-2025 | Orgovyx |
| Amag Pharmaceuticals, INC. | $80.12 | 2019-2021 | |
| Menarini Silicon Biosystems, INC. | $66.94 | 2024 | |
| Puma Biotechnology, INC. | $66.13 | 2020-2024 | |
| Springworks Therapeutics, INC. | $64.03 | 2024-2025 | Ogsiveo |
| Alnylam Pharmaceuticals INC. | $63.48 | 2021-2022 | |
| Secura Bio, INC. | $61.93 | 2019-2020 | |
| Agios Pharmaceuticals, INC. | $60.95 | 2020-2025 | Pyrukynd |
| Protega Pharmaceutials INC | $60.82 | 2024 | Roxybond |
| G1 Therapeutics, INC. | $55.10 | 2022 | |
| Apellis Pharmaceuticals, INC. | $54.66 | 2022-2024 | Empaveli |
| Coherus Oncology, INC. | $53.45 | 2020-2022 | |
| Tactile Systems Technology INC | $52.77 | 2024 | Flexitouch Plus, Entre Plus |
| Lexicon Pharmaceuticals, INC. | $40.18 | 2019 | |
| Epizyme, INC. | $39.18 | 2021 | |
| Adc Therapeutics America, INC. | $39.05 | 2022 | |
| Cti Biopharma Corp. | $38.14 | 2022 | |
| Blue Earth Diagnostics | $36.52 | 2022-2024 | |
| Verastem, INC. | $30.52 | 2019 | |
| Iovance Biotherapeutics, INC. | $24.46 | 2025 | Amtagvi |
| Acrotech Biopharma INC. | $24.12 | 2025 | Beleodaq |
| Fennec Pharmaceuticals, INC. | $22.63 | 2025 | Fyarro |
| Recordati_rare_diseases_inc. | $22.60 | 2024 | Sylvant |
| Immunogen, INC. | $22.06 | 2024 | Elahere |
| Digestive Care, INC. | $22.02 | 2024 | Pertzye |
| Deciphera Pharmaceuticals INC. | $17.54 | 2024 | Qinlock |
| Teva Pharmaceuticals USA, INC. | $17.49 | 2023 | Truxima |
| Heron Therapeutics, INC. | $17.47 | 2023 | Sustol |
| Janssen Pharmaceuticals, INC | $17.19 | 2020 | |
| Caris Mpi, INC. | $15.91 | 2025 | Mi Cancer Seek |
| Cvrx, INC. | $15.19 | 2025 | Barostim Neo System |
| Beone Medicines USA, INC. | $15.15 | 2025 | Brukinsa |
| Immunocore Limited | $14.98 | 2024 | Kimmtrak |
| Shire North American Group INC | $14.96 | 2019 | |
| Medtronic USA, INC. | $12.54 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Monoferric $114KJakafi $62KLibtayo $7,669Cabometyx $3,982Besremi $3,339Imfinzi $3,163Orserdu $2,693Nubeqa $1,019Xofigo $1,019Truqap $525Keytruda $495Darzalex $473Enhertu $473Reblozyl $368Tecvayli $299Carvykti $297Monjuvi $287Imbruvica $283Tukysa $283Lynparza $278Krazati $250Xtandi $249Lenvima $235Epkinly $227Orgovyx $227Trodelvy $226Opdivo $198Elrexfio $197Kisqali $189Talvey $172Zejula $170Rybrevant $170Fabhalta $167Adcetris $150Fyarro $147Scemblix $143Padcev $136Ibrance $134Talzenna $133Phesgo $130Niktimvo $124Erleada $123Fruzaqla $121Rezlidhia $118Tavalisse $118Polivy $118Ultomiris $113Mektovi $113Braftovi $113Jemperli $113Vonjo $112Calquence $111Clonoseq $102Sarclisa $101Tivdak $101Pluvicto $98.62Abecma $98.21Inlyta $97.88Welireg $95.65Xpovio $95.22Onivyde $90.71Da Vinci Surgical System $89.69Pertzye $88.08Ojjaara $87.64Accrufer $84.72Yescarta $83.30Lunsumio $82.33Columvi $82.33Perjeta $82.02Akeega $79.88Gilotrif $76.76Ayvakit $76.38Elahere $75.66Myrisk $75.15Vitrakvi $74.07Stivarga $74.07Venclexta $73.35Mekinist $72.59Brukinsa $70.48Alunbrig $67.99Cellsearch $66.94Alecensa $64.18Ogsiveo $64.03Bosulif $63.96Zoladex $63.62Lupron Depot $60.86Roxybond $60.82Balversa $60.61Fotivda $55.93Entre Plus $52.77Flexitouch Plus $52.77Jaypirca $50.51Rozlytrek $49.81Ninlaro $48.94Pemazyre $47.15Cablivi $45.29Enjaymo $45.29Jevtana $44.53Xalkori $43.70Lorbrena $43.70
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.